Oral rather than intravenous corticosteroids should be used to treat MS relapses - Commentary.
Health Sciences Centre, University of Calgary, Calgary, AB, Canada/Multiple Sclerosis Program, Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.
Jodie M
JM
Burton
D000305:Adrenal Cortex Hormones; D006801:Humans; D008775:Methylprednisolone; D012008:Recurrence
D000305:Adrenal Cortex Hormones; D008775:Methylprednisolone